
IntegraLab®
Your customized (c)GMP radiopharmacy
- Radiopharmacy
- Single point of contact
- Tailor-made solution
- Expert to expert, all the way
IBA works with you and supports you right through the process from our first meeting till design, setting up and operation. You’ll be working with us in a long-lasting relationship, a partnership based on trust and respect, from expert to expert.
- Direct access to the expert who knows
A single point of contact will manage the establishment of your radiopharmacy, and at the same time, you’ll have direct access to all IBA in-house experts to support you.

Our integrated solution. Your piece of mind.
We take care of everything - the equipment, building layout, GMP standards, local regulations, over integration all the way up to operations and throughout your product lifecycle.
IntegraLab® is the sum of these individual elements.

Advice on building design

Selection of equipment

Manufacturing of cyclotron

Quality & Regulatory standards

Advice regarding environmental impact

Installation of the cyclotron

Integration of 3rd parties

Quality control & process validation
IntegraLab® is the entire life cycle of your radiopharmacy, managed for you
- Now & in the future
with our continuously evolving innovations and expertise
- Single point of contact
backed up by a full IBA IntegraLab® team of experts
- Tailor the solution to your needs
IntegraLab® is your customized integrated radiopharmacy solution, seamlessly combining equipment and services tailored to meet your needs.
- Reduce your project time
By working in partnership - expert to expert – we can get the job done on budget and on time, with a solution that complies with (c)GMP standards and produces your radiotracers efficiently.
- Increase your production uptime
When your new production facility is up and running, IBA continues to offer you support and expertise. We help you to optimize uptime, maintain cutting-edge performance throughout the lifetime of your facility and maximize your return on investment.
- Stay ahead of time
For as long as you operate your facility, we will work with you and help you secure your future by offering improvements. Through R&D partnership opportunities and access to a large user’s base, IBA Radio Pharma Solutions will help you stay ahead of time.



"IBA has provided outstanding support in the preparation for the hot cell integration and the installation of the new cyclotron. Their expertise and recommendations have been invaluable, ensuring that all technical and regulatory requirements were addressed on time. We look forward to the next phases of the project with confidence."

Interested to learn more about the IntegraLab®?
Download product information
Find out everything you need to know about IntegraLab®

- 13/11/2013
IntegraLab® presentation on IBA booth during EANM 2013
- 13/10/2022
IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, GhanaLouvain-La-Neuve, Belgium, October 13, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces a new contract with Sweden Ghana Medical Centre (SGMC) for an IntegraLab® PLUS in Accra, Ghana. SGMC is a leading private cancer care center focused on providing the highest quality cancer treatment in West Africa. The contract marks IBA’s increasing presence in the region with operations in 21 countries.
IntegraLab® PLUS is a fully integrated solution that combines equipment and services for establishing a radiopharmaceutical GMP production center, tailored to each customer’s specific needs. The contract includes the delivery of an IntegraLab® solution, consisting of the installation and integration of a Cyclone® KIUBE 100 with Synthera® Extension, Synthera®+ HPLC and IFP loader. Sweden Ghana Medical Center will benefit from IBA's expertise for the complete setting-up of its radiopharmacy.
This contract follows several others signed in Tanzania and South Africa, and further highlights IBA’s ambition to broaden access to cancer diagnostics and treatments in regions of the world with low population density and limited access to healthcare. The demand for diagnostic and therapeutic equipment in Africa is rapidly growing, with cancer cases rising to over 800 000 cases* per year in Sub-Saharan Africa.
This latest announcement follows IBA’s launch of the Cyclone® KEY in January this year, which will provide more widespread global access to diagnostic solutions in oncology, neurology and cardiology as it answers a demand from the African market for a compact radiopharmaceuticals production solution.
Olivier Legrain, Chief Executive Officer at IBA, commented: “This contract marks an important milestone for IBA as we expand the use of our technology into emerging markets such as Africa. Continued innovation from our RadioPharma Solutions Business Unit is vital to providing patients with access to much needed diagnostics and treatments, something that is core to IBA’s mission and reinforced by the continued development of our technology. We look forward to working with SGMC and to helping them to achieve their mission of being at the forefront of cancer care in Africa.”
Dr. Clement Edusa, CEO and Medical Director at Sweden Ghana Medical Centre, added: “At SGMC, our vision is to provide the best possible cancer care across West Africa. The IntegraLab® will allow us to provide the most innovative diagnostic imaging tests to our patients, with the hope that we can identify disease and therefore start an appropriate course of treatment much quicker. IBA’s technology, not only provides us with a cost efficient and user-friendly cyclotron system but also tailored solutions that meet our specific needs, allowing us to provide the best possible care to our patients.”

- 20/04/2023
Discover IntegraLab®IntegraLab® is a fully integrated solution, combining equipment and services for establishing a radiopharmaceutical GMP production centre tailored to your precise needs. Our approach is truly comprehensive, taking your project from building design through to ongoing production with full regulatory compliance and the selection, integration, installation and qualification of equipment that meets your radioisotope production goals.
